Antibodies to tumour necrosis factor α as treatment for Crohn's disease-Reference-Cited by-同舟云学术

Antibodies to tumour necrosis factor α as treatment for Crohn's disease

Published:2000-03 Issue:9207 Volume:355 Page:858-860
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Bell Sally,Kamm Michael A

Publisher

Elsevier BV

Subject

General Medicine

Reference15 articles.

1. Chimeric anti-TNF-alpha monoclonal antibody cA2 binds recombinant transmembrane TNF-alpha and activates immune effector functions;Scallon;Cytokine,1995

2. Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's disease [see comments];Stack;Lancet,1979

3. A randomized, double-blind, placebo-controlled, multi-centre trial of the engineered human antibody to TNF (CDP571) for the induction and maintenance of clinical improvement in patients with moderate to severely active Crohn's disease;Sandborn;Gut,1999

4. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's disase cA2 Study Group;Targan;N Engl J Med,1997

5. Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: a European multicenter trial;D'Haens;Gasroenterology,1999

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autoimmune hematological disorders;Molecular Hematology 4e;2019-09-20

2. Infliximab;Meyler's Side Effects of Drugs;2016

3. Microglial Activation as a Compelling Target for Treating Acute Traumatic Brain Injury;Current Medicinal Chemistry;2015-01-20

4. Efficacy of thalidomide on trinitrobenzene sulfonate-induced colitis in young rats and its mechanism;Chinese Medical Journal;2014-06-20

5. Etanercept Reduces Neuroinflammation and Lethality in Mouse Model of Japanese Encephalitis;The Journal of Infectious Diseases;2014-03-20